Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Reprod Biomed Online ; 38(5): 816-824, 2019 May.
Artigo em Inglês | MEDLINE | ID: mdl-30910395

RESUMO

RESEARCH QUESTION: What is the cumulative effect of two follicle-stimulating hormone receptor (FSHR) mutations in spontaneous ovarian hyperstimulation syndrome (sOHSS) pathogenesis? Are these mutations in the mono- or biallelic state? DESIGN: Two FSHR mutations were found in a pregnant patient affected by sOHSS with no predisposing conditions. While the p.Asn106His mutation is novel, the p.Ser128Tyr mutation has been associated with sOHSS previously. The patient's FSHR gene was analysed by Sanger sequencing, and FSHR cDNAs carrying a single or both point mutations were created by mutagenesis in vitro. cAMP activation by recombinant FSH, luteinizing hormone (LH), human chorionic gonadotropin (HCG) and thyroid-stimulating hormone (TSH) was evaluated in transfected HEK293 cells by bioluminescence resonance energy transfer. RESULTS: All mutations decreased the 50% effective concentration of FSH calculated for cAMP (P < 0.05, n = 6), resulting in two- to 10-fold lower ligand potency. TSH failed to induce an FSHR-mediated increase in intracellular cAMP, while LH was approximately four-fold more potent than HCG in p.Ser128Tyr FSHR-expressing HEK293 cells despite lower cAMP plateau levels (P < 0.05, n = 5). The p.Ser128Tyr FSHR mutation was found to be responsible for an LH-/HCG-induced increase in cAMP when it was in the biallelic heterozygous state with p.Asn106His, but no increase in cAMP was induced in the monoallelic state. CONCLUSION: In-vitro data support that, in pregnant patients with sOHSS, the two FSHR mutations have an opposing effect on the pathogenesis of sOHSS and are in the biallelic heterozygous form, allowing HCG to induce a p.Ser128Tyr FSHR-mediated increase in cAMP.


Assuntos
Síndrome de Hiperestimulação Ovariana/genética , Receptores do FSH/genética , Adulto , AMP Cíclico/metabolismo , Feminino , Hormônio Foliculoestimulante/metabolismo , Células HEK293 , Humanos , Síndrome de Hiperestimulação Ovariana/metabolismo , Receptores do FSH/metabolismo
2.
Reprod Biol Endocrinol ; 11: 114, 2013 Dec 16.
Artigo em Inglês | MEDLINE | ID: mdl-24341917

RESUMO

BACKGROUND: Some data suggest that the results of human in vitro fertilization (IVF) may be affected by the site of the uterine cavity where embryos are released. It is not yet clear if there is an optimal range of embryo-fundus distance (EFD) within which embryos should be transferred to optimize IVF outcome. METHODS: The present study included 1184 patients undergoing a blind, clinical-touch ET of 1-2 fresh embryos loaded in a soft catheter with a low amount of culture medium. We measured the EFD using transvaginal US performed immediately after ET, with the aim to assess (a) if EFD affects pregnancy and implantation rates, and (b) if an optimal EFD range can be identified. RESULTS: Despite comparable patients' clinical characteristics, embryo morphological quality, and endometrial thickness, an EFD between 5 and 15 mm allowed to obtain significantly higher pregnancy and implantation rates than an EFD above 15 mm. The abortion rate was much higher (although not significantly) when EFD was below 5 mm than when it was between 5 and 15 mm. Combined together, these results produced an overall higher ongoing pregnancy rate in the group of patients whose embryos were released between 5 and 15 mm from the fundal endometrial surface. CONCLUSIONS: The site at which embryos are released affects IVF outcome and an optimal EFD range exists; this observations suggest that US-guided ET could be advantageous vs. clinical-touch ET, as it allows to be more accurate in releasing embryos within the optimal EFD range.


Assuntos
Transferência Embrionária/métodos , Adulto , Implantação do Embrião , Feminino , Humanos , Gravidez , Taxa de Gravidez , Estudos Prospectivos , Resultado do Tratamento , Ultrassonografia , Útero/diagnóstico por imagem
3.
J Assist Reprod Genet ; 29(9): 869-75, 2012 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-22644636

RESUMO

OBJECTIVE: To compare early vs. mid-follicular exposure to LH in patients with poor ovarian responsiveness undergoing in vitro fertilization (IVF). DESIGN: Prospective, randomized, controlled trial. SETTING: University Hospital, University-affiliated private Clinic. PATIENTS: Five hundred-thirty women with poor ovarian responsiveness during the first IVF cycle, undergoing their second IVF attempt. INTERVENTIONS: In a GnRH-analogue long protocol, ovarian stimulation with recombinant FSH (300 IU/day) plus randomly assigned addition of recombinant LH (150 IU/day) from day 1 (early LH exposure; n = 264) or from day 7 (late LH exposure; n = 266). MAIN OUTCOME MEASURE(S): Primary outcome was the number of oocytes retrieved. Secondary outcomes were: cancellation rate, total gonadotropin dose, duration of ovarian stimulation, number of embryos available for transfer, pregnancy rate per started cycle, per OPU and per embryo transfer, implantation rate, delivered/ongoing pregnancy rate. RESULTS: Apart from the totally administered LH dose, that was significantly higher in the group receiving it from day 1, all parameters related to IVF outcome were non significantly different in the two groups. CONCLUSIONS: Adding LH to FSH from day 1 or from day 7 of ovarian stimulation in a GnRH-agonist long protocol exerts comparable effects on IVF outcome in poor responders.


Assuntos
Fertilização in vitro/métodos , Hormônio Foliculoestimulante/uso terapêutico , Ovário/efeitos dos fármacos , Indução da Ovulação/métodos , Resultado da Gravidez , Adulto , Transferência Embrionária/métodos , Embrião de Mamíferos/efeitos dos fármacos , Feminino , Hormônio Foliculoestimulante/administração & dosagem , Hormônio Liberador de Gonadotropina/agonistas , Hormônio do Crescimento Humano/administração & dosagem , Hormônio do Crescimento Humano/uso terapêutico , Humanos , Hormônio Luteinizante/administração & dosagem , Hormônio Luteinizante/uso terapêutico , Recuperação de Oócitos/métodos , Gravidez , Taxa de Gravidez , Estudos Prospectivos , Proteínas Recombinantes/administração & dosagem , Proteínas Recombinantes/uso terapêutico , Resultado do Tratamento
4.
Reprod Biomed Online ; 20(7): 873-9, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20418165

RESUMO

Over the last century, most industrialized countries have experienced a progressive increase in maternal age at first pregnancy and a reduction of fertility rate, with important social and economic consequences. Moreover in Italy a very restrictive law on assisted reproductive technologies was introduced in 2004, limiting its effectiveness and causing a strong public debate that unfortunately focused more on the political and ethical implications of the law than on the medical and technical aspects of assisted reproduction. The present study performed an epidemiological investigation among the students of Turin University in the year 2006/07 in order to assess three aspects: the factors affecting the decision to become parents, their level of consciousness about human reproduction and their level of knowledge about the legal rules that regulate assisted reproduction in Italy. The study also wanted to clarify how the sex (male or female) and the type of education (sciences or humanities) could affect their opinions and knowledge in this area. It was observed that young people consider parenthood an important part of their life, but knowledge about human fertility and legal rules regulating assisted reproduction is rather poor, regardless of sex and type of education.


Assuntos
Serviços de Planejamento Familiar , Fertilidade , Técnicas de Reprodução Assistida/legislação & jurisprudência , Adulto , Feminino , Conhecimentos, Atitudes e Prática em Saúde , Humanos , Itália , Masculino , Idade Materna , Gravidez , Universidades
5.
Gynecol Endocrinol ; 25(7): 455-9, 2009 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-19499413

RESUMO

Ovarian hyperstimulation syndrome (OHSS) is rather frequent (1-5%) in women submitted to superovulation with gonadotropins for in vitro fertilisation (IVF), whereas it is very rare in case of spontaneous ovulation. Spontaneous OHSS (sOHSS) was previously described to be associated to hydatiform mole, multiple conception, hypothyroidism in pregnancy. It may also depend on activating mutations of the FSH receptor (FSHR) gene that cause ovarian hyper-responsiveness to circulating FSH or even cross-responsiveness of FSHR to hormones having a structure similar to FSH, such as hCG or TSH. We report, herein, a case of sOHSS in a woman who conceived spontaneously. We checked the presence of all possible factors that could explain the onset of the syndrome, and we evidenced hypothyroidism and abnormally elevated hCG levels in the second trimester of pregnancy. The thorough molecular biology study of FSHR gene did not detect exonic mutations, but revealed the presence of intronic mutations whose role in the onset of sOHSS is still uncertain.


Assuntos
Fertilização , Síndrome de Hiperestimulação Ovariana/genética , Complicações na Gravidez/genética , Receptores do FSH/genética , Adulto , Gonadotropina Coriônica/sangue , Feminino , Humanos , Hipotireoidismo/complicações , Hipotireoidismo/genética , Íntrons/genética , Mutação , Síndrome de Hiperestimulação Ovariana/complicações , Gravidez , Complicações na Gravidez/diagnóstico , Segundo Trimestre da Gravidez
6.
Obstet Gynecol Surv ; 62(12): 803-11, 2007 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-18005457

RESUMO

UNLABELLED: Fertility preservation in young girls affected by malignancies has got growing relevance in the last decade due to the improved survival chance of these patients after oncostatic treatments. Most studies have focused on preserving ovarian follicles and avoiding premature ovarian failure, whereas only a few have evaluated the effects exerted by radiotherapy and chemotherapy on the uterus. It is self-evident that fertility preservation after oncostatic therapies must include the maintenance of a functional uterus, and a certain degree of uterine damage must be considered when estimating reproductive prognosis in previously treated, childhood cancer survivors. TARGET AUDIENCE: Obstetricians & Gynecologists, Family Physicians. LEARNING OBJECTIVES: After completion of this article, the reader should be able to recall the growing number of children who survive oncostatic treatments, explain the possible effects on future reproductive endeavors, and summarize the possible ways to preserve fertility.


Assuntos
Fertilidade/efeitos dos fármacos , Fertilidade/efeitos da radiação , Neoplasias/tratamento farmacológico , Neoplasias/radioterapia , Doenças Uterinas/etiologia , Adulto , Criança , Feminino , Humanos , Infertilidade Feminina/etiologia , Infertilidade Feminina/prevenção & controle , Ovário/efeitos dos fármacos , Ovário/efeitos da radiação , Gravidez , Insuficiência Ovariana Primária/etiologia , Lesões por Radiação/complicações , Sobreviventes , Útero/efeitos dos fármacos , Útero/efeitos da radiação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA